Med. praxi. 2015;12(5):227-230

Antibiotic therapy

MUDr.Václava Adámková
Klinická mikrobiologie a ATB centrum Ústavu lékařské biochemie
a laboratorní diagnostiky 1. LF UK a VFN, Praha

Antibiotic therapy of bacterial infections is based on in vitro activity, clinical efficacy and safety and epidemiological safety. Right choice

of antibiotic reflects its pharmacokinetic and pharmacodynamic properties. The spectrum of causative agents is unchanged, but their

resistance to antimicrobial agents is increasing. Knowledge of local epidemiology is essential.

Keywords: antibiotic, resistance, de-escalation

Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adámková V. Antibiotic therapy. Med. praxi. 2015;12(5):227-230.
Download citation

References

  1. Davey PG, Marwick C. Appropriate vs. inappropriate antimicrobial therapy. Clin Microbiol Infect 2008; 14(Suppl 3): 15-21. Go to original source... Go to PubMed...
  2. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract. 1996; 43: 56-62.
  3. Dowell J, Pitkethly M, Bain J, et al. A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care. Br J Gen Pract. 2001; 51: 200-205.
  4. Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce antibiotic use in respiratory tract infections? A systematic review. Br J Gen Pract. 2003; 53: 871-877. Go to original source...
  5. Piccoli GB, Consiglio V, Colla I, et al. Antibiotic treatment for acute "uncomplicated" or "primary" pyelonephritis: a systematic, "semantic revision"; Int J Antimicrob Agents, 28. August 2006; (Suppl 1): 49-63. Go to original source... Go to PubMed...
  6. Naber KG, Schito G, Botto H, et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54(5): 1164-1175. Go to original source... Go to PubMed...
  7. Bartoníčková K, Bébrová E, Beneš J, et al. Doporučený postup pro antibiotickou léčbu komunitních infekcí ledvin a močových cest v primární péči. Prakt. Lék. 2006; 86: 429-438.
  8. Andes D, Craig WA. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations. AAC, 1998; 42: 2375-2379. Go to original source... Go to PubMed...
  9. Levy SB. Antibiotický paradox. Jak se nesprávným používáním antibiotik ruší jejich léčebná moc. Praha: Academia, 2007.
  10. Drusano GL. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. Nat Rev Microbiol 2004; 2: 289-300. Go to original source... Go to PubMed...
  11. Craig WA. The Role of Pharmacodynamics in effective treatment of Community-acquired pathogens. Advances Studies in Medicine 2002; 2(4): 126-134.
  12. Peterson LR, Hamilton JD, Baron EJ. Role of clinical microbiology laboratories in the management and control of infectious diseases and delivery of health care. Clin. Inf. Dis. 2001; 32: 605-611. Go to original source...
  13. Jevons MP. "Celbenin" - resistant Staphylococci. Brit. Med. J. 1961: 124. Go to original source...
  14. Peet NP. Drug resistance: a growing problem, Drug Discov Today (2010), doi:10.1016/j.drudis.2010.04.002. Go to original source... Go to PubMed...
  15. Mandell G, Bennett JE, Dolin R: Principles and practise of infectious diseases, ed 7, Churchill Livingstone, New York, 2010
  16. Lee C. Therapeutic challenges in the era of antibiotic resistance. Int J antimicrob agents 2008; 32(Suppl 4): 197-199. Go to original source... Go to PubMed...
  17. Bronzwaer SL, Cars O, Buchholz U. A European study on relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 2002; 8: 278-282. Go to original source... Go to PubMed...
  18. http://www.szu.cz/pracovni-skupina-pro-monitorovani-rezistence-psmr.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.